Published by Pinnacle Pulse, maker of a self-tracking app. We have no affiliate or sales relationship with any peptide seller. Editorial policy →
Is GHK-Cu legal? Cosmetic and drug rules in the EU and the US
By Pinnacle Pulse Editorial Team · Status as of 16 October 2026 · Next scheduled update: 14 January 2027
Short answer: GHK-Cu is legal to sell as a cosmetic ingredient in the EU and the US, within cosmetics rules. It is not authorized as a medicine in either. Once a product is presented as treating a disease or changing how the body works, it can fall under drug law instead. FDA has taken injectable GHK-Cu out of the compounding process. WADA does not name it. This is general information, not legal advice.
At a glance
| Where | Status on 16 October 2026 |
|---|---|
| EU | Used in cosmetics under Regulation (EC) No 1223/2009; no medicine authorization |
| US | Cosmetic use possible; non-injectable GHK-Cu in 503A Category 1, injectable GHK-Cu withdrawn; advisory committee review due by end of February 2027 |
| WADA | Not named on the 2027 list; WADA warns that peptides it doesn’t name may still be prohibited |
The line between cosmetic and medicine
Nearly every legal question about GHK-Cu comes back to one distinction. A cosmetic is for cleaning, perfuming, protecting or changing how the outside of your body looks. A medicine is for treating or preventing disease, or for restoring, correcting or modifying how the body works. The same molecule can land on either side. What decides it is what the product is for and what the seller claims.
FDA’s own explainer puts it plainly: intended use is what counts, and intent can be read from labels, websites, even social media posts. Promise that a cream will regenerate cells, for instance, and you are drifting into drug territory. EU cosmetics and medicines law works from similar definitions.
European Union
EU cosmetics fall under Regulation (EC) No 1223/2009. Nobody approves a face cream before it goes on sale. But someone in the EU has to be named as the responsible person, there has to be a safety report, and the product has to be notified through the EU’s cosmetics portal. Claims have to meet the common criteria in Regulation (EU) No 655/2013, including that there is adequate evidence behind them. In the EU’s cosmetic ingredient database, CosIng, the copper complex is listed as copper tripeptide-1.
A vial sold for injection is obviously not a cosmetic, and EMA’s medicines data list no GHK-Cu medicine.
United States
US cosmetics, apart from color additives, don’t need FDA approval before sale. Drugs do. A skin cream with cosmetic claims and an injectable product are therefore in very different places.
For pharmacy compounding, FDA lists GHK-Cu, excluding injectable forms, in Category 1 of its 503A list, which means pharmacies may use it while FDA does its evaluation. There was a brief hiccup: the entry was removed in April 2026 and put back after FDA clarified in May that only the injectable nomination had been withdrawn. FDA plans to take GHK-Cu to its Pharmacy Compounding Advisory Committee before the end of February 2027. Injectable GHK-Cu sits on FDA’s list of withdrawn substances, with possible immune reactions and limited human data named as concerns.
Sport
WADA’s 2027 list doesn’t mention GHK-Cu. Could it fall under S0? That class catches pharmacological substances not covered elsewhere on the list and not approved by any health authority for human therapeutic use, and the 2027 version names peptides as an example. WADA’s notes to the 2027 List add that a peptide not named on the List may still be prohibited. WADA’s guidance on cosmetics says creams on intact skin are unlikely to cause a positive test, but that this won’t work as an excuse if one happens. Athletes should ask their national anti-doping organization before using such products.
What the research does not show
Legal as a cosmetic ingredient is not the same as proven. Cosmetics skip approval, and a 2025 review of GHK-Cu found a surprising absence of clinical studies. For injected GHK-Cu, FDA cites limited human data. See [GHK-Cu: what the research shows](/research/ghk-cu).FAQ
Is GHK-Cu legal in the EU?
As a cosmetic ingredient, yes, within the rules of the EU Cosmetics Regulation. It is not authorized as a medicine, and products sold as medicines or for injection fall under different rules.
Is GHK-Cu legal in the US?
It can be sold in cosmetics, which don’t need FDA approval. Non-injectable GHK-Cu is in FDA’s Category 1 for compounding pharmacies. FDA removed the injectable form from the compounding process, citing safety concerns.
Is GHK-Cu banned in sport?
WADA does not name it, but it notes that peptides missing from the List may still be prohibited. Athletes should check with their anti-doping organization before using any product containing it.
Sources
- European Commission. Cosmetics legislation: Regulation (EC) No 1223/2009 and Regulation (EU) No 655/2013. single-market-economy.ec.europa.eu
- FDA. Is it a cosmetic, a drug, or both? (Or is it soap?) fda.gov
- FDA. Bulk drug substances nominated for use in compounding under section 503A: categories. fda.gov/media/94155/download
- FDA. Certain bulk drug substances for use in compounding that may present significant safety risks. fda.gov
- WADA. The Prohibited List, including FAQ on cosmetic products. wada-ama.org
- European Commission. CosIng cosmetic ingredient database, entry COPPER TRIPEPTIDE-1, checked 16 October 2026. ec.europa.eu
- EMA. Download medicine data: table of all medicines assessed by EMA (Excel), checked 16 October 2026. ema.europa.eu
- WADA. 2027 Prohibited List, full text (PDF), checked 16 October 2026. wada-ama.org
- WADA. 2027 Prohibited List: summary of major modifications and explanatory notes (PDF), checked 16 October 2026. wada-ama.org
Facts last checked: 16 October 2026.
About this article
Written by: the Pinnacle Pulse Editorial Team, the people who make the Pinnacle Pulse app. We work only from primary sources such as regulators, legal texts, trial registries and PubMed, and we remove claims we can’t check against one.
This page has not been reviewed by a lawyer. It is general information, not legal advice.
Spotted an error? Our editorial policy explains how to report it and how we correct mistakes.
Change log
- 16 October 2026: First published.
From the makers of this site: Pinnacle Pulse is a neutral tracking app. We don’t sell or recommend any substance. About Pinnacle Pulse
This page is general information about the law as of the date shown. It is not legal advice. For your own situation, consult a lawyer.